2018 | Laboratorio Reig Jofre

3 August 2018

Transactions within the share buyback program

3 August 2018

Start of the trading of the new shares following the scrip dividend

30 July 2018

Transactions within the share buyback program

26 July 2018

Reig Jofre releases first half 2018 results note

25 July 2018

Start of the third Temporary Share Buyback Program

17 July 2018

Scrip dividend: bonus-shares capital increase and new shares to be issued

21 June 2018

Start of coverage through three equity research reports

14 June 2018

Scrip dividend: beginning of the trading period of the allotment rights

7 June 2018

Remuneration through the scrip dividend or flexible dividend

8 May 2018

Results note: First quarter 2018

3 May 2018

Resolutions on the general shareholders’ meeting

9 April 2018

Investment plan to expand the injectable products plant of Barcelona

23 March 2018

Convening of the Ordinary and Extraordinary General Shareholders’ Meeting

23 March 2018

Reig Jofre and Leanbio create the joint venture Syna Therapeutics for the development of biosimilar products

2 March 2018

Presentation of 2017 results

28 February 2018

Results preview: Year 2017

20 February 2018

Reig Jofre informs on the presentation of 2017 results

26 January 2018

Publication schedule for 2018 results

24 January 2018

Launch in France of a new nutritional supplement of Forté Pharma

5 January 2018

Transactions within the share buyback program